{"id":30075,"date":"2021-04-01T12:00:00","date_gmt":"2021-04-01T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/"},"modified":"2021-04-01T12:00:00","modified_gmt":"2021-04-01T12:00:00","slug":"verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/nl\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/","title":{"rendered":"Verkenning van nieuwe behandelingen met biologicals in de astmazorg"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1230 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>Veel mensen worden behandeld voor ernstig, ongecontroleerd astma, wat gepaard gaat met een hoog risico op ziekenhuisopname. Aan sommige mensen met verschillende soorten astma werd een nieuw type behandeling aangeboden naast hun gebruikelijke astmamedicijnen: monoklonale antilichamen, ook wel biologicals genoemd. <\/p>\n<p>Professor Michael Wechsler van het National Jewish Health Hospital in Denver, VS, wiens onderzoek zich richt op nieuwe astmatherapie\u00ebn en de behandeling van astma en aanverwante ziekten met biologicals, bespreekt de huidige uitdagingen in de astmazorg bij het gebruik van biologicals. U ontdekt hoe behandeling met biologicals de symptomen van astma kan verbeteren en astma-aanvallen kan verminderen, leert de verschillen tussen de behandeling met biologicals en de klassieke astmabehandeling, en ontdekt welke groepen pati\u00ebnten waarschijnlijk succesvol behandeld kunnen worden met therapie met biologicals. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1231 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-videospeler\" src=\"https:\/\/www.youtube.com\/embed\/SSqD9hM40SM?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Veel mensen worden behandeld voor ernstig, ongecontroleerd astma, wat gepaard gaat met een hoog risico op ziekenhuisopname. Aan sommige mensen met verschillende soorten astma werd een nieuw type behandeling aangeboden naast hun gebruikelijke astmamedicijnen: monoklonale antilichamen, ook wel biologicals genoemd. Professor Michael Wechsler van het National Jewish Health Hospital in Denver, VS, wiens onderzoek zich richt op nieuwe astmatherapie\u00ebn en de behandeling van astma en aanverwante ziekten met biologicals, bespreekt de huidige uitdagingen in de astmazorg bij het gebruik van biologicals. U ontdekt hoe behandeling met biologicals de symptomen van astma kan verbeteren en astma-aanvallen kan verminderen, leert de verschillen tussen de behandeling met biologicals en de klassieke astmabehandeling, en ontdekt welke groepen pati\u00ebnten waarschijnlijk succesvol behandeld kunnen worden met therapie met biologicals.<\/p>\n","protected":false},"author":1,"featured_media":30092,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[149],"tags":[154,155,165,181,223],"class_list":["post-30075","news","type-news","status-publish","has-post-thumbnail","hentry","category-euforea-news-shows","tag-zorgverleners","tag-euforea-nieuws","tag-behandelingen","tag-biologicals","tag-astma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Verkenning van nieuwe behandelingen met biologicals in de astmazorg - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verkenning van nieuwe behandelingen met biologicals in de astmazorg\" \/>\n<meta property=\"og:description\" content=\"Veel mensen worden behandeld voor ernstig, ongecontroleerd astma, wat gepaard gaat met een hoog risico op ziekenhuisopname. Aan sommige mensen met verschillende soorten astma werd een nieuw type behandeling aangeboden naast hun gebruikelijke astmamedicijnen: monoklonale antilichamen, ook wel biologicals genoemd. Professor Michael Wechsler van het National Jewish Health Hospital in Denver, VS, wiens onderzoek zich richt op nieuwe astmatherapie\u00ebn en de behandeling van astma en aanverwante ziekten met biologicals, bespreekt de huidige uitdagingen in de astmazorg bij het gebruik van biologicals. U ontdekt hoe behandeling met biologicals de symptomen van astma kan verbeteren en astma-aanvallen kan verminderen, leert de verschillen tussen de behandeling met biologicals en de klassieke astmabehandeling, en ontdekt welke groepen pati\u00ebnten waarschijnlijk succesvol behandeld kunnen worden met therapie met biologicals.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/\",\"name\":\"Verkenning van nieuwe behandelingen met biologicals in de astmazorg - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png\",\"datePublished\":\"2021-04-01T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/nl\\\/kies-uw-traject\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Verkenning van nieuwe behandelingen met biologicals in de astmazorg\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Verkenning van nieuwe behandelingen met biologicals in de astmazorg - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/","og_locale":"nl_NL","og_type":"article","og_title":"Verkenning van nieuwe behandelingen met biologicals in de astmazorg","og_description":"Veel mensen worden behandeld voor ernstig, ongecontroleerd astma, wat gepaard gaat met een hoog risico op ziekenhuisopname. Aan sommige mensen met verschillende soorten astma werd een nieuw type behandeling aangeboden naast hun gebruikelijke astmamedicijnen: monoklonale antilichamen, ook wel biologicals genoemd. Professor Michael Wechsler van het National Jewish Health Hospital in Denver, VS, wiens onderzoek zich richt op nieuwe astmatherapie\u00ebn en de behandeling van astma en aanverwante ziekten met biologicals, bespreekt de huidige uitdagingen in de astmazorg bij het gebruik van biologicals. U ontdekt hoe behandeling met biologicals de symptomen van astma kan verbeteren en astma-aanvallen kan verminderen, leert de verschillen tussen de behandeling met biologicals en de klassieke astmabehandeling, en ontdekt welke groepen pati\u00ebnten waarschijnlijk succesvol behandeld kunnen worden met therapie met biologicals.","og_url":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/","url":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/","name":"Verkenning van nieuwe behandelingen met biologicals in de astmazorg - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png","datePublished":"2021-04-01T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Exploring20Novel20Biologics20Treatment20in20Asthma20Care.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/verkenning-van-nieuwe-behandelingen-met-biologicals-in-de-astmazorg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/nl\/kies-uw-traject\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Verkenning van nieuwe behandelingen met biologicals in de astmazorg"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/30075","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/comments?post=30075"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/news\/30075\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media\/30092"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/media?parent=30075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/categories?post=30075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/nl\/wp-json\/wp\/v2\/tags?post=30075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}